SCHEMBL7797715

SCHEMBL7797715

O=C(O)c1c(Cl)ccc(NS(=O)(=O)Cc2ccccc2)c1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 2/20 0.50
HPGD P15428 3/20 0.47
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
HSD17B10 Q99714 2/20 0.47
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
MMP1 P03956 1/20 0.45
MMP2 P08253 1/20 0.45
MMP9 P14780 1/20 0.45
MMP8 P22894 1/20 0.45
MMP13 P45452 1/20 0.45
F2 P00734 2/20 0.44
PRSS1 P07477 1/20 0.44
PRSS2 P07478 1/20 0.44
PRSS3 P35030 1/20 0.44
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
GAA P10253 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL913580 0.79 BRAF (0.55) HPGDKDM4EALDH1A1HSD17B10KMT2A
SCHEMBL1462229 0.77 BRAF (0.42)
SCHEMBL6795655 0.77 BRAF (0.48)
SCHEMBL3983370 0.75 METAP2 (0.64) ACLYHPGDKDM4EALDH1A1HSD17B10
SCHEMBL6137932 0.73 ACLY (0.69) ACLYHPGDKDM4EALDH1A1HSD17B10
SCHEMBL4357672 0.72 GLO1 (0.51) ACLYHPGDKDM4EALDH1A1HSD17B10
SCHEMBL13510428 0.72 MCL1 (0.60) ACLYHPGDKDM4EALDH1A1HSD17B10
SCHEMBL7686172 0.72 ACLY (0.71) ACLYHPGDKDM4EALDH1A1HSD17B10
SCHEMBL14563534 0.72 ALDH1A1 (0.46) ACLYHPGDKDM4EALDH1A1HSD17B10
SCHEMBL22315270 0.71 KMT2A (0.59) ACLYHPGDKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0623592-B1 Peptide analogs as irreversible interleukin-1beta protease inhibitors VERTEX PHARMA (US) 2001-06-27 EP disclosed
EP-0623592-A1 Peptide analogs as irreversible interleukin-1beta protease inhibitors STERLING WINTHROP INC. (US) 1994-11-09 EP disclosed